Pharmaceutical Form - Ready to fill pelletsStrengths - 30%Release Characteristic - Sustained Release (50 mg Capsules)Indications - Relieves pain and reduces inflammation that may occur in rheumatoid arthritis or osteoarthritisPosology - Twice dailyRaw Material -Not availableTechnical Documents - Technical package availableRegistration underway - UzbekistanMarketing - Egypt, Syria, Yemen, Sudan